Friday Pop Quiz 12/26/2025
What is the underlying gene defect for this transgrediens form of palmoplanter keratoderma?
A. SLURP-1
B. TOC gene
C. Plakoglobin
D. Keratin type 1
E. Keratin type 9
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
*Brand partners had no involvement in the content of the questions or answers. …
What is the underlying gene defect for this transgrediens form of palmoplanter keratoderma?
A. SLURP-1
B. TOC gene
C. Plakoglobin
D. Keratin type 1
E. Keratin type 9
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
*Brand partners had no involvement in the content of the questions or answers. … 
Transitioning from residency to your first dermatology position is one of the most exciting and intimidating steps in your career. The job you choose (and the contract you sign) will shape not only your salary but also your professional development, work-life balance, and long-term satisfaction. It is crucial to learn how to evaluate job benefits before you sit down at the negotiating table to avo … 
GLP-1 receptor agonists are revolutionizing the treatment of type 2 diabetes and obesity. With widespread consumer advertising campaigns, GLP-1 usage is becoming commonplace. National polls show up to one-fifth of American adults have tried GLP-1s for weight loss or to address health conditions, such as heart disease. As the understanding of GLP-1s deepens, so does their potential. Since recent re … 
What immunohistochemical stain is most likely to be positive in this condition?
A. HPV
B. HHV-8
C. PAS
D. S100
E. CD207
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
*Brand partners had no involvement in the content of the questions or answers. … 
Hyaluronic acid (HA) fillers are widely used in aesthetic medicine for facial rejuvenation, volumization, and wrinkle treatment. Noninflammatory nodules after HA filler injection are a relatively common phenomenon and a result of poor technique or a large volume bolus in one area.¹ Unlike these nodules, delayed-onset nodules (DON) occur in 0.5% of injections and can be inflammatory, granulomatou …